Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
PacificHealth Laboratories Inc
PHLICurrent price
0.0001 USD
0 USD (0.00%)
Last closed
0.0001 USD
Company
www.pacifichealthlabs.com
ISIN
US6951131001
Sector
Consumer Defensive
Industry
Household & Personal Products
Exchange
PINK
Capitalization
438 307 USD
Yield for 12 month
0.00 %
1Y
3Y
5Y
10Y
15Y
PHLI
PacificHealth Laboratories, Inc. engages in the development of nutritional products that enhance health and athletic performance in the United States and internationally. It primarily focuses on sports performance, hydration, fueling, and muscle recovery. The company provides ENDUROX R4, a muscle recovery drink; ACCELERADE protein powered sports drink; ACCEL GEL, a energy gel; Body Glove Surge; ENDUROX EXCEL, an exercise supplement; and 2ND SURGE, an ultra energy gel. It also offers ACCELERADE HYDRO for less intense workouts use before, during, and after workouts for hydration, energy, and recovery. The company markets its products to various distribution channels, including sports specialty and natural product retailers and chains, as well as markets their products through its Website. PacificHealth Laboratories, Inc. was founded in 1995 and is based in Matawan, New Jersey. Address: 100 Matawan Road, Matawan, NJ, United States, 07747
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
2.8 USDP/E ratio
–Dividend Yield
–Current Year
+6 914 818 USD
Last Year
+7 200 960 USD
Current Quarter
+1 721 119 USD
Last Quarter
+2 229 234 USD
Current Year
+2 987 523 USD
Last Year
+3 163 628 USD
Current Quarter
+585 103 USD
Last Quarter
+866 105 USD
Key Figures PHLI
1 year
3 years
5 years
10 years
EBITDA
-861 233 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-24.6 %
PEG Ratio
–
Return On Equity TTM
-74.61 %
Wall Street Target Price
2.8 USD
Revenue TTM
6 667 649 USD
Book Value
0.04 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-12.7 %
Dividend Yield
–
Gross Profit TTM
2 987 523 USD
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
III 2012
Quarterly Earnings Growth YOY
–
Profit Margin
-14.15 %
Dividend Analytics PHLI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PHLI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation PHLI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.0858
Price Sales TTM
0.0657
Enterprise Value EBITDA
-0.6644
Price Book MRQ
0.7066
Financials PHLI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PHLI
For 52 weeks
0.0001 USD
0.0001 USD
50 Day MA
0.0001 USD
Shares Short Prior Month
1 350
200 Day MA
0.0001 USD
Short Ratio
0.28
Shares Short
–
Short Percent
–
BeatStart